Dose Adjustments to Concomitant Antiseizure Medications: Post-hoc Analysis of a Phase 3, Open-Label Study of Cenobamate for Treatment of Uncontrolled Focal Seizures

被引：0

作者：

Rosenfeld, William E. ^{[1
]}

Abou-Khalil, Bassel ^{[2
]}

Aboumatar, Sami ^{[3
]}

Bhatia, Perminder ^{[4
]}

Biton, Victor ^{[5
]}

Klein, Pavel ^{[6
]}

Krauss, Gregory L. ^{[7
]}

Sperling, Michael R. ^{[8
]}

Vossler, David G. ^{[9
]}

Wechsler, Robert ^{[10
]}

机构：

[1] Comprehens Epilepsy Care Ctr Children & Adults, New York, NY USA

[2] Vanderbilt Univ, Med Ctr, Nashville, TN USA

[3] Austin Epilepsy Care Ctr, Austin, TX USA

[4] Neuro Pain Med Ctr, Fresno, CA USA

[5] Arkansas Epilepsy Program, Little Rock, AR USA

[6] Mid Atlantic Epilepsy & Sleep Ctr, North Bethesda, MD USA

[7] Johns Hopkins Univ, Baltimore, MD 21218 USA

[8] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA

[9] Univ Washington, Sch Med, Seattle, WA 98195 USA

[10] Idaho Comprehens Epilepsy Ctr, Boise, ID USA

来源：

NEUROLOGY | 2021年 / 96卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

1755

引用

页数：5

共 50 条

[21] Safety of Cenobamate (YKP3089) as Adjunctive Treatment for Uncontrolled Focal Seizures in Large, Multicenter, Open-Label Study
Sperling, Michael
Klein, Pavel
Kamin, Marc
NEUROLOGY, 2019, 92 (15)
[22] Safety of Cenobamate as Adjunctive Treatment for Uncontrolled Focal Seizures: Results from a Large, International, Safety Open-Label Study
Sanchez-Alvarez, J.
Santamarina, E.
Milanov, I.
Winter, Y.
Brandt, C.
Fabo, D.
EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 437 - 437
[23] Efficacy and safety of adjunctive cenobamate: Post-hoc analysis of study C017 in patients grouped by mechanism of action of concomitant antiseizure medications
Brandt, Christian
Carlos Sanchez-Alvarez, Juan
Steinhoff, Bernhard J.
Milanov, Ivan
Serratosa, Jose M.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2022, 96 : 86 - 93
[24] Number of seizure-free days with adjunctive cenobamate: post-hoc analysis of an open-label extension study
Brandt, C.
Fabo, D.
Milovanovic, M.
Alvarez-Baron, E.
Thangavelu, K.
Milanov, I.
EPILEPSIA, 2023, 64 : 58 - 58
[25] Number of seizure-free days with adjunctive cenobamate: post-hoc analysis of an open-label extension study
Brandt, C.
Fabo, D.
Milovanovic, M.
Alvarez-Baron, E.
Thangavelu, K.
Milanov, I.
EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 171 - 171
[26] Effect of Number of Previous Antiseizure Medications on Efficacy and Tolerability of Adjunctive Brivaracetam for Uncontrolled Focal Seizures: Post Hoc Analysis
Sang-Kun Lee
Kyoung Heo
Sung-Eun Kim
Sang-Ahm Lee
Sami Elmoufti
Cédric Laloyaux
Boeun Hur
Advances in Therapy, 2021, 38 : 4082 - 4099
[27] Effect of Number of Previous Antiseizure Medications on Efficacy and Tolerability of Adjunctive Brivaracetam for Uncontrolled Focal Seizures: Post Hoc Analysis
Lee, Sang-Kun
Heo, Kyoung
Kim, Sung-Eun
Lee, Sang-Ahm
Elmoufti, Sami
Laloyaux, Cedric
Hur, Boeun
ADVANCES IN THERAPY, 2021, 38 (07) : 4082 - 4099
[28] Sustainability of seizure reduction and seizure control with adjunctive cenobamate: Post hoc analysis of a phase 3, open-label study
Vossler, David G. G.
Rosenfeld, William E. E.
Stern, Sean
Wade, Clarence T. T.
Ferrari, Louis
Kerr, Wesley T. T.
Wechsler, Robert
EPILEPSIA, 2023, 64 (10) : 2644 - 2652
[29] Efficacy of adjunctive cenobamate based on number of concomitant antiseizure medications, seizure frequency, and epilepsy duration at baseline: A post-hoc analysis of a randomized clinical study
Rosenfeld, William E.
Nisman, Arkady
Ferrari, Louis
EPILEPSY RESEARCH, 2021, 172
[30] Long-term Safety of Adjunctive Cenobamate in Patients with Uncontrolled Focal Seizures: Open-label Extension of a Randomized Clinical Study
Chung, Steve S.
French, Jaqueline
Krauss, Gregory L.
Lee, Sang Kun
Maciejowski, Maciej
Rosenfeld, William E.
Sperling, Michael R.
Kamin, Marc
NEUROLOGY, 2020, 94 (15)

← 1 2 3 4 5 →